188 related articles for article (PubMed ID: 19910632)
1. Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism.
Higuchi A; Ohashi K; Shibata R; Sono-Romanelli S; Walsh K; Ouchi N
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):46-53. PubMed ID: 19910632
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression.
Higuchi A; Ohashi K; Kihara S; Walsh K; Ouchi N
Circ Res; 2009 May; 104(9):1058-65. PubMed ID: 19342600
[TBL] [Abstract][Full Text] [Related]
3. Response of experimental retinal neovascularization to thiazolidinediones.
Murata T; Hata Y; Ishibashi T; Kim S; Hsueh WA; Law RE; Hinton DR
Arch Ophthalmol; 2001 May; 119(5):709-17. PubMed ID: 11346398
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction.
Tao L; Wang Y; Gao E; Zhang H; Yuan Y; Lau WB; Chan L; Koch WJ; Ma XL
Circ Res; 2010 Feb; 106(2):409-17. PubMed ID: 19940263
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
Li P; Shibata R; Unno K; Shimano M; Furukawa M; Ohashi T; Cheng X; Nagata K; Ouchi N; Murohara T
Hypertension; 2010 Jan; 55(1):69-75. PubMed ID: 19933924
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality.
Uji Y; Yamamoto H; Tsuchihashi H; Maeda K; Funahashi T; Shimomura I; Shimizu T; Endo Y; Tani T
Surgery; 2009 May; 145(5):550-7. PubMed ID: 19375615
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin deficiency promotes the production of inflammatory mediators while severely exacerbating hepatic injury in mice with polymicrobial sepsis.
Uji Y; Yamamoto H; Maeda K; Tsuchihashi H; Akabori H; Shimizu T; Endo Y; Shimomura I; Tani T
J Surg Res; 2010 Jun; 161(2):301-11. PubMed ID: 19481767
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.
Gardiner TA; Gibson DS; de Gooyer TE; de la Cruz VF; McDonald DM; Stitt AW
Am J Pathol; 2005 Feb; 166(2):637-44. PubMed ID: 15681845
[TBL] [Abstract][Full Text] [Related]
9. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.
Gao C; Liu Y; Yu Q; Yang Q; Li B; Sun L; Yan W; Cai X; Gao E; Xiong L; Wang H; Tao L
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1583-91. PubMed ID: 25888509
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways.
Kubota T; Kubota N; Sato H; Inoue M; Kumagai H; Iwamura T; Takamoto I; Kobayashi T; Moroi M; Terauchi Y; Tobe K; Ueki K; Kadowaki T
Sci Rep; 2016 Oct; 6():34707. PubMed ID: 27703271
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin/adipoR1/AMPK pathway.
Quaresma PG; Reencober N; Zanotto TM; Santos AC; Weissmann L; de Matos AH; Lopes-Cendes I; Folli F; Saad MJ; Prada PO
Int J Obes (Lond); 2016 Jan; 40(1):138-46. PubMed ID: 26228462
[TBL] [Abstract][Full Text] [Related]
12. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.
Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S
Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
15. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy.
McVicar CM; Hamilton R; Colhoun LM; Gardiner TA; Brines M; Cerami A; Stitt AW
Diabetes; 2011 Nov; 60(11):2995-3005. PubMed ID: 21911748
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
Kubota N; Terauchi Y; Kubota T; Kumagai H; Itoh S; Satoh H; Yano W; Ogata H; Tokuyama K; Takamoto I; Mineyama T; Ishikawa M; Moroi M; Sugi K; Yamauchi T; Ueki K; Tobe K; Noda T; Nagai R; Kadowaki T
J Biol Chem; 2006 Mar; 281(13):8748-55. PubMed ID: 16431926
[TBL] [Abstract][Full Text] [Related]
17. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone reduces tumor necrosis factor-alpha serum concentration and mRNA expression of adipose tissue in hypercholesterolemic rabbits.
Wu ZH; Zhao SP; Chu LX; Ye HJ
Int J Cardiol; 2010 Jan; 138(2):151-6. PubMed ID: 18809217
[TBL] [Abstract][Full Text] [Related]
20. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
